447 related articles for article (PubMed ID: 19118846)
1. Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice.
Kakizaki T; Kohno M; Watanabe M; Tajima A; Izumi Y; Miyasho T; Tasaka S; Fukunaga K; Maruyama I; Ishizaka A; Kobayashi K
J Surg Res; 2009 Jun; 154(2):336-44. PubMed ID: 19118846
[TBL] [Abstract][Full Text] [Related]
2. Occult injury in the residual lung after pneumonectomy in mice.
Tajima A; Kohno M; Watanabe M; Izumi Y; Tasaka S; Maruyama I; Miyasho T; Kobayashi K
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1114-20. PubMed ID: 18713778
[TBL] [Abstract][Full Text] [Related]
3. The effects of hemodilution on acute inflammatory responses in a bleomycin-induced lung injury model.
Cheong SH; Lee JH; Lee KM; Cho KR; Yang YI; Seo JY; Yoon SY; Lee JN; Choi MY; Lee SE; Kim YH; Lim SH
Exp Lung Res; 2009 Dec; 35(10):841-57. PubMed ID: 19995278
[TBL] [Abstract][Full Text] [Related]
4. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury.
Smith RE; Strieter RM; Phan SH; Lukacs N; Kunkel SL
J Leukoc Biol; 1998 Oct; 64(4):528-36. PubMed ID: 9766634
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis.
Kim JW; Rhee CK; Kim TJ; Kim YH; Lee SH; Yoon HK; Kim SC; Lee SY; Kwon SS; Kim KH; Kim YK
Clin Exp Pharmacol Physiol; 2010 Nov; 37(11):1055-63. PubMed ID: 20659133
[TBL] [Abstract][Full Text] [Related]
6. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
7. [The pivotal role of CXCR3 in the pathogenesis of bleomycin-induced pulmonary fibrosis].
Gao JM; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jan; 28(1):28-32. PubMed ID: 15774188
[TBL] [Abstract][Full Text] [Related]
8. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin.
Kradin RL; Sakamoto H; Jain F; Zhao LH; Hymowitz G; Preffer F
Exp Mol Pathol; 2004 Jun; 76(3):205-11. PubMed ID: 15126102
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
10. 16,16-Dimethyl prostaglandin E2 efficacy on prevention and protection from bleomycin-induced lung injury and fibrosis.
Failla M; Genovese T; Mazzon E; Fruciano M; Fagone E; Gili E; Barera A; La Rosa C; Conte E; Crimi N; Cuzzocrea S; Vancheri C
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):50-8. PubMed ID: 19059888
[TBL] [Abstract][Full Text] [Related]
11. IL-12p40(-/-) mice treated with intratracheal bleomycin exhibit decreased pulmonary inflammation and increased fibrosis.
Sakamoto H; Zhao LH; Jain F; Kradin R
Exp Mol Pathol; 2002 Feb; 72(1):1-9. PubMed ID: 11784117
[TBL] [Abstract][Full Text] [Related]
12. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
13. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
14. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice.
Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A
Am J Respir Cell Mol Biol; 2008 May; 38(5):566-71. PubMed ID: 18096870
[TBL] [Abstract][Full Text] [Related]
15. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
Ren YX; Zhou R; Tang W; Wang WH; Li YC; Yang YF; Zuo JP
Acta Pharmacol Sin; 2007 Apr; 28(4):518-25. PubMed ID: 17376291
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
17. The role of high mobility group box1 in pulmonary fibrosis.
Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
[TBL] [Abstract][Full Text] [Related]
18. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
20. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
Furonaka M; Hattori N; Tanimoto T; Senoo T; Ishikawa N; Fujitaka K; Haruta Y; Yokoyama A; Kohno N
J Pharmacol Exp Ther; 2009 Jan; 328(1):55-61. PubMed ID: 18832650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]